SCHEMBL263379

SCHEMBL263379

COC(C)OC.COCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782 0.83
SCHEMBL7806168 0.80
SCHEMBL107064 0.80
SCHEMBL787284 0.80
SCHEMBL8668896 0.80
SCHEMBL19531 0.80
SCHEMBL16193434 0.80
SCHEMBL439660 0.80
SCHEMBL21405143 0.80
SCHEMBL1024872 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019233579-A1 ORGANOPOLYSILOXANES THAT CROSS-LINK AT ROOM TEMPERATURE WACKER CHEMIE AG (DE) 2019-12-12 WO disclosed
US-10252251-B2 Production of organic materials using solid catalysts BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2019-04-09 US disclosed
US-20170057903-A1 PRODUCTION OF ORGANIC MATERIALS USING SOLID CATALYSTS BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NV, RENO (US) 2017-03-02 US disclosed
EP-2694524-B1 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES US HEALTH (US) 2016-05-18 EP disclosed
US-9284343-B2 2′-O-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-03-15 US disclosed
US-20140051846-A1 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES TheUnited ofAmerica,asrepresentedbythe Secre -tary,Department ofHealthand Human Service (US) 2014-02-20 US disclosed
WO-2013036665-A1 COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO SATORI PHARMACEUTICALS, INC. (US) 2013-03-14 WO disclosed
WO-2013036669-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2013-03-14 WO disclosed
US-20130060020-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20130060019-A1 Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20030236263-A1 Chemical compounds LILLY ICOS LLC, A DELAWARE CORPORATION 2003-12-25 US disclosed
US-5110800-A Derivatives of erythromycylamine ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
EP-0238178-B1 NOVEL DERIVATIVES OF ERYTHROMYCYLAMINE ELI LILLY AND COMPANY (US) 1990-06-27 EP disclosed
EP-0209541-B1 OPEN CHAIN-MORPHOLINO ADRIAMYCINS SRI INTERNATIONAL (US) 1989-10-11 EP disclosed
EP-0238178-A1 Novel derivatives of erythromycylamine ELI LILLY AND COMPANY (US) 1987-09-23 EP disclosed
EP-0209541-A1 OPEN CHAIN-MORPHOLINO ADRIAMYCINS. STANFORD RES INST INT (US) 1987-01-28 EP disclosed
WO-1986004332-A1 OPEN CHAIN-MORPHOLINO ADRIAMYCINS SRI INTERNATIONAL (US) 1986-07-31 WO disclosed
US-4591637-A Open chain-morpholino adriamycins SRI INTERNATIONAL (US) 1986-05-27 US disclosed
US-4444764-A INSECTICIDES THE DOW CHEMICAL COMPANY (US) 1984-04-24 US disclosed
EP-0023841-A2 5 Pyrimidinol phosphorus esters, and methods for their manufacture, compositions containing those esters and their use as pesticides THE DOW CHEMICAL COMPANY (US) 1981-02-11 EP disclosed